Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B

There are few studies comparing the safety and immunogenicity of the same HIV immunogen in healthy volunteers and HIV-infected individuals. We analyzed demographics, adverse events (AEs), and immunogenicity against vaccinia virus in preventive (RISVAC02, n = 24 low-risk HIV-negative volunteers) and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccines (Basel)
Main Authors: Couto, Elvira, Diaz-Brito, Vicenç, Mothe, Beatriz, Guardo, Alberto C., Fernandez, Irene, Ugarte, Ainoa, Etcheverry, Flor, Gómez, Carmen E., Esteban, Mariano, Pich, Judit, Arnaiz, Joan Albert, López Bernaldo de Quirós, Juan Carlos, Brander, Christian, Plana, Montserrat, García, Felipe, Leal, Lorna
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963361/
https://ncbi.nlm.nih.gov/pubmed/31703287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines7040178
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados